Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

638
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
638
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

683
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
683
Assessment of the Cardiovascular System III: Palpation01:27

Assessment of the Cardiovascular System III: Palpation

1.6K
Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
1.6K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

2.0K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.0K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

852
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
852
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

767
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
767

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective purification and chemical labeling of a target protein on ruthenium photocatalyst-functionalized affinity beads.

Chemical communications (Cambridge, England)·2017
Same author

Increased Soluble CD226 in Sera of Patients with Cutaneous T-Cell Lymphoma Mediates Cytotoxic Activity against Tumor Cells via CD155.

The Journal of investigative dermatology·2017
Same author

CXCL17 Attenuates Imiquimod-Induced Psoriasis-like Skin Inflammation by Recruiting Myeloid-Derived Suppressor Cells and Regulatory T Cells.

Journal of immunology (Baltimore, Md. : 1950)·2017
Same author

Serum LL-37 levels correlate with the efficacy of i.v. cyclophosphamide pulse for skin sclerosis and interstitial lung disease in systemic sclerosis.

The Journal of dermatology·2017
Same author

The impact of transcription factor Fli1 deficiency on the regulation of angiogenesis.

Experimental dermatology·2017
Same author

Critical contribution of the interleukin-6/signal transducer and activator of transcription 3 axis to vasculopathy associated with systemic sclerosis.

The Journal of dermatology·2017

Related Experiment Video

Updated: Apr 7, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.1K

Vasculopathy in scleroderma.

Yoshihide Asano1, Shinichi Sato

  • 1Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan, yasano-tky@umin.ac.jp.

Seminars in Immunopathology
|July 9, 2015
PubMed
Summary
This summary is machine-generated.

Systemic sclerosis (SSc) involves vascular injury and fibrosis due to autoimmune factors. Understanding SSc vasculopathy pathogenesis is key to developing effective treatments for this multisystem connective tissue disorder.

More Related Videos

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

3.5K
Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases
07:47

Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases

Published on: December 6, 2016

7.7K

Related Experiment Videos

Last Updated: Apr 7, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.1K
Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

3.5K
Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases
07:47

Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases

Published on: December 6, 2016

7.7K

Area of Science:

  • Rheumatology and Immunology
  • Vascular Biology
  • Pathogenesis of Fibrotic Diseases

Background:

  • Systemic sclerosis (SSc) is a complex connective tissue disease characterized by autoimmune-driven vascular injury and fibrosis.
  • The precise pathogenesis of SSc, particularly its vascular manifestations, remains incompletely understood.
  • Vascular abnormalities are central to SSc, leading to organ damage and fibrosis.

Purpose of the Study:

  • To provide an overview of the current understanding of the pathogenesis of vasculopathy in Systemic Sclerosis.
  • To elucidate the structural and functional vascular abnormalities characteristic of SSc.
  • To highlight recent advancements that offer insights into SSc vascular development.

Main Methods:

  • Review of existing literature on SSc pathogenesis and vasculopathy.
  • Analysis of structural vascular changes, including destructive and proliferative obliterative vasculopathy.
  • Examination of functional vascular impairments, such as endothelial dysfunction and altered coagulation.

Main Results:

  • SSc vasculopathy involves both structural damage (vessel loss, occlusion) and functional deficits (endothelial dysfunction, impaired nitric oxide availability).
  • Key mechanisms include altered cell adhesion molecule expression, endothelial-to-mesenchymal transition, and dysregulated coagulation/fibrinolysis.
  • Impaired vasculogenesis and angiogenesis contribute to the destructive vascular alterations in SSc.
  • Recent therapeutic insights and animal models offer new perspectives on SSc vascular pathology.

Conclusions:

  • Vascular injury is a critical initiating event in Systemic Sclerosis pathogenesis, leading to widespread fibrosis.
  • Understanding the multifaceted nature of SSc vasculopathy is essential for targeted therapeutic strategies.
  • Continued research into SSc vascular mechanisms, aided by new models and therapeutic data, is crucial for advancing patient care.